William T. Symonds is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis C virus (HCV) infection. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Symonds' latest patents focus on compositions and methods for treating hepatitis C virus. One of his key inventions includes a composition and unit dosage form for the treatment of HCV infection, which comprises GS-7977 and at least one pharmaceutically acceptable excipient. The patent also outlines methods for making this composition and unit dosage form. Furthermore, it describes a method of treating a subject infected with HCV, which involves administering an effective amount of GS-7977 and ribavirin. Notably, this method can produce an undetectable amount of HCV RNA in the subject for at least 12 weeks after treatment.

Career Highlights

William T. Symonds is currently associated with Gilead Pharmasset LLC, where he continues to innovate in the pharmaceutical field. His work is characterized by a commitment to developing effective treatments for viral infections, particularly hepatitis C.

Collaborations

Symonds has collaborated with esteemed colleagues such as Darryl G. Cleary and Charles J. Reynolds. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

William T. Symonds is a prominent inventor whose work in hepatitis C treatment showcases his dedication to medical innovation. His contributions have the potential to change the landscape of HCV treatment and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.